Technical Analysis for CRSP - CRISPR Therapeutics AG
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| Earnings Movers | Other | 0.00% | |
| Death Cross | Bearish | -0.59% | |
| Bollinger Band Squeeze | Range Contraction | -0.59% | |
| Earnings Movers | Other | -0.59% | |
| Bollinger Band Squeeze | Range Contraction | -0.20% | |
| Down 3 Days in a Row | Weakness | -0.20% | |
| Down 4 Days in a Row | Weakness | -0.20% | |
| Gapped Down | Weakness | -0.20% | |
| Fell Below 20 DMA | Bearish | -2.01% |
| Alert | Time |
|---|---|
| Fell Below Previous Day's Low | 1 day ago |
| Down 1% | 1 day ago |
| Possible NR7 | 1 day ago |
| Possible Inside Day | 1 day ago |
| 60 Minute Opening Range Breakdown | 1 day ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/30/2024
Crispr Therapeutics AG is a Switzerland-based gene-editing company. The Company focuses on the development of transformative gene-based medicines for serious diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 gene-editing platform. CRISPR/Cas9 can be programmed to cut, edit and correct disease-associated deoxyribonucleic acid (DNA) in a patient’s cell. The location at which the Cas9 molecular scissors cut the DNA to be edited is specified by guide ribonucleic acid (RNA), which is comprised of a crRNA component and a tracrRNA component, either individually or combined together as a single guide RNA. The Company has business operations in London, the United Kingdom, as well as research and development operations in Cambridge, the United States.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Immune System Acid Genetics Enzymes Genetic Engineering Precision Medicine DNA CRISPR Genome Editing Cas9
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Immune System Acid Genetics Enzymes Genetic Engineering Precision Medicine DNA CRISPR Genome Editing Cas9
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 91.1 |
| 52 Week Low | 37.55 |
| Average Volume | 1,285,147 |
| 200-Day Moving Average | 59.54 |
| 50-Day Moving Average | 58.87 |
| 20-Day Moving Average | 55.06 |
| 10-Day Moving Average | 55.07 |
| Average True Range | 2.45 |
| RSI (14) | 41.52 |
| ADX | 13.35 |
| +DI | 18.62 |
| -DI | 21.13 |
| Chandelier Exit (Long, 3 ATRs) | 51.82 |
| Chandelier Exit (Short, 3 ATRs) | 58.38 |
| Upper Bollinger Bands | 57.87 |
| Lower Bollinger Band | 52.25 |
| Percent B (%b) | 0.27 |
| BandWidth | 10.22 |
| MACD Line | -1.15 |
| MACD Signal Line | -1.35 |
| MACD Histogram | 0.2001 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 55.77 | ||||
| Resistance 3 (R3) | 55.88 | 55.31 | 55.43 | ||
| Resistance 2 (R2) | 55.31 | 54.79 | 55.25 | 55.32 | |
| Resistance 1 (R1) | 54.52 | 54.47 | 54.24 | 54.42 | 55.21 |
| Pivot Point | 53.95 | 53.95 | 53.81 | 53.90 | 53.95 |
| Support 1 (S1) | 53.17 | 53.43 | 52.88 | 53.06 | 52.27 |
| Support 2 (S2) | 52.60 | 53.11 | 52.54 | 52.16 | |
| Support 3 (S3) | 51.81 | 52.60 | 52.05 | ||
| Support 4 (S4) | 51.71 |
